Lactobacillus plantarum 299v for the treatment of recurrent Clostridium difficile-associated diarrhoea: a double-blind, placebo-controlled trial

Clicks: 215
ID: 270937
2003
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
A double-blind, placebo-controlled trial was performed to analyse the ability of Lactobacillus plantarum 299v to prevent further recurrent episodes of Clostridium difficile-associated diarrhoea (RCDAD). Recurrence of clinical symptoms (main outcome) was seen in 4 of 11 patients who received metronid …
Reference Key
m2003scandinavianlactobacillus Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Wullt M;Hagslätt ML;Odenholt I;;
Journal scandinavian journal of infectious diseases
Year 2003
DOI DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/12953945
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine research support non-u.s. gov't female male aged middle aged Recurrence Clinical Trial Randomized Controlled Trial Double-Blind Method metronidazole / therapeutic use enterocolitis probiotics / therapeutic use* pseudomembranous / therapy* pmid:12953945 doi:10.1080/00365540310010985 marlene wullt marie-louise johansson hagslätt inga odenholt clostridioides difficile / physiology* lactobacillus / physiology*

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.